Total planned funding: $674,951,844
Clear active filters
Ethiopia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Ethiopia | $674,951,844 |
Organizational Types
Unknown | $139,099,672 |
Private Contractor | $120,307,005 |
Host Country Government Agency | $114,578,036 |
NGO | $103,655,660 |
University | $59,213,129 |
Own Agency | $57,842,843 |
Implementing Agency | $53,420,787 |
Multi-lateral Agency | $18,256,502 |
Other USG Agency | $5,650,265 |
FBO | $2,927,945 |
Program Areas
Treatment | $225,482,063 |
Care | $162,818,803 |
Prevention | $108,098,154 |
Governance and Systems | $98,045,472 |
Testing | $42,318,688 |
Management and Operations | $38,188,664 |
Budget Codes
HTXS: Treatment: Adult Treatment | $192,876,466 |
HKID: Care: Orphans and Vulnerable Children | $68,922,941 |
HBHC: Care: Adult Care and Support | $61,029,840 |
HVOP: Sexual Prevention: Other Sexual Prevention | $54,255,723 |
OHSS: Health Systems Strengthening | $45,863,543 |
HVCT: Testing: HIV Testing and Counseling | $42,318,688 |
HVMS: Management and Operations | $38,188,664 |
HVSI: Strategic Information | $32,254,047 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $30,276,551 |
HVTB: Care: TB/HIV | $20,248,998 |
HLAB: Laboratory Infrastructure | $19,927,882 |
PDTX: Treatment: Pediatric Treatment | $16,876,041 |
HTXD: Treatment: ARV Drugs | $15,729,556 |
PDCS: Care: Pediatric Care and Support | $12,617,024 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,755,756 |
HMIN: Biomedical Prevention: Injection Safety | $7,196,616 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $4,929,457 |
HMBL: Biomedical Prevention: Blood Safety | $3,684,051 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$121,934,102
Countries/Regions
Chemonics International:
$50,786,211
Countries/Regions
Columbia University:
$44,407,203
Countries/Regions
USG Aggregated Agencies:
$37,220,803
Countries/Regions